BACKGROUND: Changes in lung density on computed tomography (CT) are common after
stereotactic ablative radiotherapy (SABR) and can confound the early detection of …

OBJECTIVES: Patients with severe chronic obstructive pulmonary disease (COPD) have a
high risk of lung cancer and of postsurgical complications. We studied outcomes after …

Chronic conditions place a high cost burden on the healthcare system and deplete the
quality of life for millions of Americans. Digital innovations such as mobile health (mHealth) …

Background and purpose Early detection of local recurrences following stereotactic ablative
radiotherapy (SABR) for lung cancer may allow for curative salvage treatment, but …

The use of stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung
cancer is growing rapidly, particularly since it has become the recommended therapy for …

We report quality of life and indirect costs from patient reported outcomes from the ROSEL
randomized control trial comparing stereotactic ablative radiotherapy (SABR, also known as …

The elderly make up the majority of non-small-cell lung cancer (NSCLC) patients, but there
is a lack of specific evidence to guide treatment; guidelines exist but elderly specific trials are …

Background: Our previous animal and preliminary human studies indicated that
bronchoscopy-guided cooled radiofrequency ablation (RFA) for the lung is a safe and …

Objectives Comparative studies of survival between stereotactic body radiation therapy
(SBRT) and surgery have been limited by lack of comparisons of recurrence patterns …

Background Patients who present with early stage non-small cell lung cancer and are poor
candidates for lobar resection may be offered sublobar resection (commonly wedge) or …